4.7 Article

From Croatian Roma to 1000 Genomes: The Story of the CYP2D6 Gene Promoter and Enhancer SNPs

期刊

JOURNAL OF PERSONALIZED MEDICINE
卷 12, 期 8, 页码 -

出版社

MDPI
DOI: 10.3390/jpm12081353

关键词

CYP2D6 gene; population genetics; Roma population; promoter; enhancer; regulation of transcription; pharmacogenomics; personalized medicine

资金

  1. Croatian Science Foundation [IP-2014-09-4454, DOK2018-01-4817]

向作者/读者索取更多资源

The Croatian Roma population shows a LD pattern of the CYP2D6 gene region similar to the European and Asian populations, with no differences between the population groups.
The CYP2D6 gene encodes an enzyme responsible for the metabolism of similar to 20% of clinically prescribed drugs. In this study, 18 SNPs from the enhancer and promoter regions of CYP2D6 in 323 Roma from Croatia were genotyped, to find out whether the demographic history of Roma affected the distribution of the studied SNPs and their linkage disequilibrium (LD) values, with the major SNPs defining the CYP2D6 star alleles. No differences were found between the three Roma groups in allele and genotype frequencies. The distribution of LD values of Roma was compared with LD values of European and Asian populations. Regulatory CYP2D6 SNPs (rs5758550, rs28624811, rs1080985 and rs1080983) showed similar distribution and the highest LDs with rs16947 from the gene-coding region in all populations. In the promoter region, a complete LD between rs1080989 and rs28588594, and between rs1080983 and rs28624811, was found in Croatian Roma and investigated populations from 1000 genomes. A high LD was also found between rs1080985 from the promoter and rs5758550 from the enhancer region. SNP rs28735595 from the gene promoter region had the highest LD, with two gene region SNPs, rs1058164 and rs1135840. To conclude, the Croatian Roma population shows an LD pattern of the CYP2D6 gene region similar to the 1000 Genomes European and Asian populations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据